MONDAY, Oct. 4, 2021 (HealthDay News) — Colon cancer numbers dropped dramatically during the COVID-19 pandemic, but that doesn’t mean fewer people have the disease. In Spain, researchers discovered a more than 40% decline in colon cancer diagnoses, leading experts to worry about the ramifications. “These are very worrying findingsContinue Reading

FRIDAY, Oct. 1, 2021 (HealthDay News) — Pharmaceutical giant Merck & Co. said Friday that it will seek federal approval for emergency use of its new antiviral pill molnupiravir, after a clinical trial showed the drug halved the risk of hospitalization or death when given to high-risk people shortly afterContinue Reading

THURSDAY, Sept. 30, 2021 (HealthDay News) — Artificial intelligence (AI) might be able to spot the next virus to jump from animals to humans, Scottish researchers report. Identifying diseases before they become a threat to humans is challenging, because only a few of the nearly 2 million animal viruses canContinue Reading

WEDNESDAY, Sept. 29, 2021 (HealthDay News) — A drug previously approved for multiple sclerosis also can treat inflammatory bowel disease in some patients, a new clinical trial reports. The medication, ozanimod (Zeposia), proved effective in helping patients with ulcerative colitis, sending many into full remission, according to results being publishedContinue Reading

WEDNESDAY, Sept. 29, 2021 (HealthDay News) — Roughly a third of Americans on high blood pressure medications do not have their blood pressure under control, a new study reveals. And younger men and older women are particularly vulnerable, researchers warn. “Although this phenomenon has been hinted at in the medicalContinue Reading